§ 63-10-215. Transfer of Prescriptions to Another Prescription Form
Pharmacists, pharmacy interns and pharmacy technicians are authorized to comply with federal and state prescription requirements, including the requirement of a separate prescription for a Schedule II controlled substance found in §§ 63-1-160, 63-7-123(b)(3)(B), and 63-19-107(2)(E)(ii), by transferring from a prescription containing a Schedule Il controlled substance any drug that is a nonscheduled prescription drug […]
§ 63-10-216. Compounding Pharmacies
Prior to initial licensure in this state as a compounding pharmacy, a pharmacy located outside of this state must have an inspection by the regulatory or licensing agency of the state in which the pharmacy practice site is physically located. Out-of-state pharmacy practice sites must provide a copy of the most recent inspection by the […]
§ 63-10-217. Collaborative Pharmacy Practice Agreements
A collaborative pharmacy practice agreement under this chapter shall be between one (1) or more pharmacists licensed in this state and an individual prescriber licensed in this state, or one (1) or more prescribers licensed in this state in an organized medical group, including but not limited to, staff of a licensed health care facility, […]
§ 63-10-218. Professional Judgment in Dispensing of Varying Quantities of Medication Not to Exceed Ninety-Day Supply — Exclusion of Controlled Substances
Unless the prescriber has specified on the prescription that dispensing a prescription for a maintenance medication in an initial amount followed by periodic refills is medically necessary, a pharmacist may exercise professional judgment to dispense varying quantities of medication per fill up to the total number of dosage units as authorized by the prescriber on […]
§ 63-10-219. Provision of Hormonal Contraceptives
As used in this section, “hormonal contraceptive” means a self-administered drug, or a transdermal patch applied to the skin of a patient, by the patient or by a practitioner, that releases a drug composed of a combination of hormones that are approved by the United States food and drug administration to prevent pregnancy. Pursuant to […]
§ 63-10-220. Facilities Engaging in Distribution of Dialysate and Devices for Home Use
This chapter does not apply to a facility to the extent the facility engages in the distribution of dialysate or devices necessary to perform home peritoneal kidney dialysis to patients with end stage renal disease if: The dialysate are comprised of dextrose or icodextrin, and the dialysate and devices are approved or cleared by the […]
§ 63-10-221. Medication Therapy Management — Standards
Medication therapy management provided under this chapter as part of the practice of pharmacy shall meet the standards for medication therapy management established by rule by the board of pharmacy.
§ 63-10-222. Medication Therapy Management Pilot Program — Reporting of Costs and Patient Outcomes
The bureau of TennCare is directed to report to the senate health and welfare committee and the committee of the house of representatives having oversight over TennCare regarding program costs and patient outcomes related to incorporating the pharmacist-provided medication therapy management pilot program on or before April 15 of each year the pilot program is […]
§ 63-10-223. Agreement Limiting Ability of Pharmacist to Discuss Issue Related to Dispensing of Controlled Substance With Patient Void and Unenforceable
The general assembly finds that patient access to information about controlled substances is crucial to combating the deadly opioid epidemic in this state and that any obstacle to patients’ receiving information about controlled substances is a serious threat to public health. Any agreement purporting to limit the ability of a pharmacist to discuss any issue […]
§ 63-10-205. Consultation on Drugs by Board to Department of Health
The board shall, at the request of the commissioner of health, provide consultation to the department of health regarding drugs to be issued by the department or by a local health clinic. The department of health shall develop policies and protocols for inventory controls, accountability, repackaging, security, storage and issuance of drugs by state and […]